FindTrial
Sign In

LOMSHATAN EFFECT OF ARAGWADHADI TAILA

A Pharmaceutico-Analytical Study of Aragwadhadi Taila and it’s Lomshatan Effect - APASATALE

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062811
Enrollment
40
Registered
2024-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Post Graduate Institute of Ayurved,Jodhpur, Rajasthan
Lead Sponsor
Dr Dharmendra Kumar Pareek
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients 16-40 year of both sexes will be selected Patients fulfilling the criteria of excessive hair growth over hands, legs and chest will be selected for assessment

Exclusion criteria

Exclusion criteria: Patients below 16 and above 40 year of both sexes. Patients having pregnancy. Patient having any allergy history or sensitivity will be excluded from study. Patient having inherited disorders or syndromes and congenital disorders will be excluded. from study. Patient having diabetes, hypertension or any metabolic disorder will be excluded from present study.

Design outcomes

Primary

MeasureTime frame
To evaluate Lomshatan Effect of Aragwadhadi TailaTimepoint: 30 days—

Secondary

MeasureTime frame
To evaluate adverse effect of Aragwadhadi TailaTimepoint: 30 days—

Countries

India

Contacts

Public ContactProf Govind Sahay Shukla

Poast Gradutate Institue Of Ayurved

dr.govindshukla@yahoo.com8769058254

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026